StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.90−0.10 (-3.33%)

Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –

Nephros operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Nephros's operating income for the twelve months ending Jun 30, 2026 was $1.64M, up 22.8% year over year. For fiscal 2025 it was $1.15M, up 19000.0% from the year before. The highest annual figure on record is $1.15M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.15M+19000.0%
FY2024Dec 31, 2024$6.00K–
FY2023Dec 31, 2023-$1.59M–
FY2022Dec 31, 2022-$4.34M–
FY2021Dec 31, 2021-$3.25M–
FY2020Dec 31, 2020-$4.28M–
FY2019Dec 31, 2019-$3.16M–
FY2018Dec 31, 2018-$3.02M–
FY2017Dec 31, 2017-$2.23M–
FY2016Dec 31, 2016-$2.87M–
FY2015Dec 31, 2015-$3.42M–
FY2014Dec 31, 2014-$2.67M–
FY2013Dec 31, 2013-$3.32M–
FY2012Dec 31, 2012-$3.33M–
FY2011Dec 31, 2011-$2.31M–
FY2010Dec 31, 2010-$1.89M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.21M+389.1%
Q1 FY2026Mar 31, 2026$97.00K-82.9%
Q4 FY2025Dec 31, 2025$18.00K-94.3%
Q3 FY2025Sep 30, 2025$314.00K+52.4%
Q2 FY2025Jun 30, 2025$248.00K–
Q1 FY2025Mar 31, 2025$566.00K–
Q4 FY2024Dec 31, 2024$317.00K–
Q3 FY2024Sep 30, 2024$206.00K–
Q2 FY2024Jun 30, 2024-$317.00K–
Q1 FY2024Mar 31, 2024-$200.00K–
Q4 FY2023Dec 31, 2023-$649.00K–
Q3 FY2023Sep 30, 2023-$203.00K–
Q2 FY2023Jun 30, 2023-$435.00K–
Q1 FY2023Mar 31, 2023-$306.00K–
Q4 FY2022Dec 31, 2022-$693.00K–
Q3 FY2022Sep 30, 2022-$1.28M–
Q2 FY2022Jun 30, 2022-$814.00K–
Q1 FY2022Mar 31, 2022-$1.55M–
Q4 FY2021Dec 31, 2021-$721.00K–
Q3 FY2021Sep 30, 2021-$802.00K–
Q2 FY2021Jun 30, 2021-$1.12M–
Q1 FY2021Mar 31, 2021-$1.02M–
Q4 FY2020Dec 31, 2020-$719.00K–
Q3 FY2020Sep 30, 2020-$932.00K–
Q2 FY2020Jun 30, 2020-$1.60M–
Q1 FY2020Mar 31, 2020-$1.03M–
Q4 FY2019Dec 31, 2019-$291.00K–
Q3 FY2019Sep 30, 2019-$695.00K–
Q2 FY2019Jun 30, 2019-$868.00K–
Q1 FY2019Mar 31, 2019-$1.30M–
Q4 FY2018Dec 31, 2018-$729.00K–
Q3 FY2018Sep 30, 2018-$511.00K–
Q2 FY2018Jun 30, 2018-$653.00K–
Q1 FY2018Mar 31, 2018-$1.12M–
Q4 FY2017Dec 31, 2017-$403.00K–
Q3 FY2017Sep 30, 2017-$518.00K–
Q2 FY2017Jun 30, 2017-$700.00K–
Q1 FY2017Mar 31, 2017-$605.00K–
Q4 FY2016Dec 31, 2016-$609.00K–
Q3 FY2016Sep 30, 2016-$637.00K–

More Nephros figures

See a number that looks wrong?